Gilead Sciences
GILD
#81
Rank
NZ$376.42 B
Marketcap
NZ$303.48
Share price
-1.45%
Change (1 day)
33.04%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): NZ-$5.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ-$5.65. In 2025 the company made an earnings per share (EPS) of NZ$12.48 an increase over its 2024 EPS that were of NZ$0.69.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.54-144.38%
2025NZ$12.481702.63%
2024NZ$0.69-91.65%
2023NZ$8.2923.98%
2022NZ$6.69-25.86%
2021NZ$9.024850%
2020NZ$0.18-97.64%
2019NZ$7.730.9%
2018NZ$7.6618.71%
2017NZ$6.45-64.88%
2016NZ$18.37-18.45%
2015NZ$22.5255.28%
2014NZ$14.51296.02%
2013NZ$3.6617.89%
2012NZ$3.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.17-315.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.29-122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.66-288.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.30-1,096.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.67-660.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$4.30-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$10.73-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$28.56-605.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.81-132.03%๐Ÿ‡บ๐Ÿ‡ธ USA